CN101199693A - Chinese medicine for oral administration for treating lumbar hyperosteogeny - Google Patents
Chinese medicine for oral administration for treating lumbar hyperosteogeny Download PDFInfo
- Publication number
- CN101199693A CN101199693A CNA2007101152976A CN200710115297A CN101199693A CN 101199693 A CN101199693 A CN 101199693A CN A2007101152976 A CNA2007101152976 A CN A2007101152976A CN 200710115297 A CN200710115297 A CN 200710115297A CN 101199693 A CN101199693 A CN 101199693A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese
- treatment
- combination
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an oral Chinese herbal combination for treating lumbar vertebrae hyperosteogeny, belonging to the Chinese traditional medicine field. The combination is prepared by Chinese Clematis Root, Szechwan Lovage Rhizome, Baikal Skullcap Root, notopterygium root, Chinese Taxillus Twig, Peach Seed, saffron, pawpaw, Radix angelicae dahuricae and angelica respectively with a certain weight. The combination is decocted for oral taking, one dose for one day and for twice taking; one period of treatment is half a month. The efficacies of the drugs mutually act to synthetically regulate, metabolize and absorb the hyperplastic part of the neurovascular organism tissues, recover the local metabolism of joints and effectively treat lumbar vertebrae hyperosteogeny combined with prolapse of lumbar intervertebral disc and spinal canal stenosis.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of lumbar vertebra hyperosteogeny, is a kind of Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration specifically.
Background technology
Hyperosteogeny is bony spur or hyperosteogeny again, is outgrowth sclerotin on the osteoarthrosis edge.Hyperosteogeny is not oppressed tissues such as peripheral nerve and blood vessel, does not just have clinical symptoms.
Lumbar vertebra hyperosteogeny disease people's symptom has aching pain in waist and back, because of slightly sprain, overworked, remove and carry weight or accidental unconscious waist incoordinate movement, producing acute attack is the flank pain aggravation, all sense difficulties are stood up in activity.
What waist bore over loading for a long time firmly is the main cause that causes lumbar vertebrae bone, heavy worker, frequent back bracket weight person pickaback, some athlete such as weight lifting, gymnastics, wrestling and other strenuous exercise, all be easy to damage lumbar vertebra, increase the weight of the strain and the regression of lumbar vertebra, lumbar vertebra hyperosteogeny occurs.
The method of state's internal therapy bone matrix hyperplasia has much at present, can divide following several substantially: the unidirectional current drug iontophoresis, its physiology therapeutical effect is except that the function of current, mainly by the pharmacological property decision that imports medicine ion, the unidirectional current drug iontophoresis has been given full play to the effect of medicine, but is liquid because of importing medicine, and is volatile, drug effect is not lasting, has limited the therapeutic effect of this method; Massage and traction, the effect of massage and the complete outer power of traction is only treated the part and has but been ignored integrally regulating in the human body, therefore, can only play temporary transient analgesic effect, and can not reach the purpose of treatment; Western medicine, at present doctor trained in Western medicine does not still have effective medicine to this disease, takes stopgap measures and does not effect a permanent cure, and the state of an illness easily recurs.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration, it has overcome the deficiency in the above-mentioned Therapeutic Method, comprehensively regulating, metabolism absorbs the hypertrophy part of compressing neural blood vessel when injected organism tissue, recover the metabolism of local joint, treat lumbar vertebra hyperosteogeny effectively and merge diseases such as prolapse of lumbar intervertebral disc, spinal canal stenosis.
Technical scheme of the present invention is: a kind of Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration is characterized in that being made by following raw material medicaments one day dosage.
Prescription: Radix Clematidis 20 grams, Rhizoma Chuanxiong 5 grams, Radix Scutellariae 10 grams, Rhizoma Et Radix Notopterygii 10 grams, Herba Taxilli 12 grams, Semen Persicae 10 grams, Stigma Croci 10 grams, Fructus Chaenomelis 20 grams, the Radix Angelicae Dahuricae 20 grams, Radix Angelicae Sinensis 15 grams.
Usage: be decocted in water for oral dose 1 dose of every day, day clothes 2 times.Two weeks is a course of treatment.
Radix Clematidis: wind-damp dispelling, the meridian dredging, expectorant saliva, the hypochondriac lump of loosing.Control gout, insensitive impediment, chills and pain of the waist and kness, tetanus, tonsillitis, all a fishbone or other bone caught in the throat pharynxs.
Rhizoma Chuanxiong: activating QI to alleviate the depression, dispeiling pathogenic wind and removing dampness, promoting blood circulation and stopping pain.Control air-cooled headache and revolve dizzyly, the hypochondriac pain abdomen is painful, arthralgia due to cold clonic spasm of the muscle, amenorrhea, difficult labour, postpartum stagnation piece pain, ulcer sores.
Radix Scutellariae: the removing the relative excess fire, except that damp and hot, hemostasis, antiabortive.Control the high fever excessive thirst, the cough due to lung-heat, damp-heat dysentery, jaundice, pyretic stranguria is told, is defeated in battle, collapses, is leaked, conjunctival congestion and swelling pain, frequent fetal movement, carbuncle furuncle.
Rhizoma Et Radix Notopterygii: the exterior cold of loosing, wind-damp dispelling, sharp joint.The wind and cold that cures cold, it is lossless to have a headache, anemofrigid-damp arthralgia, stiffness of the nape muscular contracture, joint ache, edema due to wind pathogen edema, skin sore.
Herba Taxilli: invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, the meridian dredging, beneficial blood, antiabortive.Control soreness of waist and knee joint, hemiplegia a little less than the muscles and bones flaccidity, beriberi, anemofrigid-damp arthralgia, vaginal bleeding during pregnancy metrorrhagia, lack of lactation after delivery.
Semen Persicae: blood stasis removing and clots absorbing, moisturize laxation.Control amenorrhea , mass in the abdomen, calentura blood-retention, migratory arthralgia, malaria, traumatic injury, swelling and pain due to blood stasis, the dry constipation of blood.
Stigma Croci: blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens.Control troubled thoughts pent-up, the chest and diaphragm painful abdominal mass is vexed, spits blood, and typhoid fever is gone mad, and is frightened fear in a trance, women's amenorrhea, postnatal blood stasis stomachache, tumbling and swelling.
Fructus Chaenomelis: suppressing the hyperactive liver and easing the stomach, damp eliminating Shujin.Control the convulsion of vomiting and diarrhoea, arthralgia chiefly caused by damp pathogen, beriberi, edema, dysentery.
The Radix Angelicae Dahuricae: dispel the wind, dampness, detumescence, headache is controlled in pain relieving, supraorbital bone pain, cold-damp stomachache, hemorrhoidal hamorrhage anal fistula, ulcer sores.
Radix Angelicae Sinensis: benefiting blood and regulating blood circulation, menstruction regulating and pain relieving is moisturized laxation.Control menoxenia, amenorrhea stomachache , mass in the abdomen knot is poly-, metrorrhagia; Headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome; The dryness of the intestine dyschezia is heavy after the bloody dysentery; The carbuncle skin ulcer is stolen, injury from falling down.
After the present invention mixed said medicine, its drug effect synergism had been obtained significant curative effect in the therapeutic process of lumbar vertebra hyperosteogeny.
Model case is as follows:
Case one, Jiang Jiali, man, 52 years old.Waist lower limb fiber crops pain, especially with the left side for very, waist function anterior flexion and rear stretching is limited, idol has twinge or electric shock sample fiber crops pain when movable, lower limb radiates left.Examine and be lumbar vertebra hyperosteogeny disease.Lumbago and skelalgia disappears after taking our two courses of treatment, and clinical symptoms all disappears after obeying two courses of treatment, after this participates in manual labor gradually, does not see recurrence.
Case two, Yu Zhimei, woman, 48 years old, people from Shanxi.Flank pain, sciatica, the outer instep of thigh gaskin radiating pain.Hospital is diagnosed as L3~L5 prolapse of lumbar intervertebral disc companion bony spur hypertrophy, uses this medicine after one course of treatment, and pain relief can be free movable; Took for second course of treatment, symptom is eliminated substantially; Fully recover after using for the 3rd course of treatment, activity and can do housework freely.
Case three, Xie Yina, the woman, 59 years old, lumbar vertebra pain showed effect 3 years repeatedly, played aggravation morning, stood up difficulty.Hospital is diagnosed as lumbar vertebra hyperosteogeny, clothes we after course of treatment pain obviously alleviate, and the pain number of times reduces.After taking for second course of treatment, all rarely seen one day pain, and can do a small amount of housework.Use after three courses of treatment, fully recover.
The specific embodiment
Embodiment one: a kind of Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration is characterized in that being made by following raw material medicaments one day dosage.Prescription: Radix Clematidis 20 grams, Rhizoma Chuanxiong 5 grams, Radix Scutellariae 10 grams, Rhizoma Et Radix Notopterygii 10 grams, Herba Taxilli 12 grams, Semen Persicae 10 grams, Stigma Croci 10 grams, Fructus Chaenomelis 20 grams, the Radix Angelicae Dahuricae 20 grams, Radix Angelicae Sinensis 15 grams.
Usage: be decocted in water for oral dose 1 dose of every day, day clothes 2 times.Two weeks is a course of treatment.
Claims (1)
1. one kind takes the Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny orally, it is characterized in that the crude drug of making effective ingredient by following weight is: Radix Clematidis 20 grams, Rhizoma Chuanxiong 5 grams, Radix Scutellariae 10 grams, Rhizoma Et Radix Notopterygii 10 grams, Herba Taxilli 12 grams, Semen Persicae 10 grams, Stigma Croci 10 grams, Fructus Chaenomelis 20 grams, the Radix Angelicae Dahuricae 20 grams, Radix Angelicae Sinensis 15 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710115297A CN100589819C (en) | 2007-12-17 | 2007-12-17 | Chinese medicine for oral administration for treating lumbar hyperosteogeny |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710115297A CN100589819C (en) | 2007-12-17 | 2007-12-17 | Chinese medicine for oral administration for treating lumbar hyperosteogeny |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101199693A true CN101199693A (en) | 2008-06-18 |
CN100589819C CN100589819C (en) | 2010-02-17 |
Family
ID=39515176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710115297A Expired - Fee Related CN100589819C (en) | 2007-12-17 | 2007-12-17 | Chinese medicine for oral administration for treating lumbar hyperosteogeny |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100589819C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104857218A (en) * | 2015-06-19 | 2015-08-26 | 青岛辰达生物科技有限公司 | Nursing drug for treating lumbar disc herniation |
-
2007
- 2007-12-17 CN CN200710115297A patent/CN100589819C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104857218A (en) * | 2015-06-19 | 2015-08-26 | 青岛辰达生物科技有限公司 | Nursing drug for treating lumbar disc herniation |
Also Published As
Publication number | Publication date |
---|---|
CN100589819C (en) | 2010-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100584369C (en) | Composition of Chinese traditional medicine for treating rheumatism | |
CN101979074B (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
CN102793883B (en) | Plaster for treating intervertebral disc protrusion and cervical spondylosis | |
CN103463356B (en) | The Chinese medicine composition for the treatment of yang deficiency arthromyodynia | |
CN104771654A (en) | Traditional Chinese medicine for treating lumbar vertebra hyperostosis and cervical vertebra hyperostosis and preparation method thereof | |
CN103263551A (en) | Powder for external use for relieving swelling and dispersing blood stasis | |
CN103479819B (en) | The Chinese prescription of traditional Chinese medicine fumigating moxibustion therapy treatment rheumatoid arthritis | |
CN101322756B (en) | Medicament for massaging and treating lumbar disease and preparation thereof | |
CN100589819C (en) | Chinese medicine for oral administration for treating lumbar hyperosteogeny | |
CN101700302A (en) | Oral traditional Chinese medicine composition for treating osteoporosis | |
CN101780257B (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
CN101502604B (en) | Chinese herbal medicine preparation for treating rheumatism | |
CN104258285A (en) | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof | |
CN110946932A (en) | Moxibustion composition and preparation method and application thereof | |
CN104027451B (en) | A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica | |
CN103735809B (en) | A kind of Chinese medicine decoction treating lumbar vertebra fracture | |
CN102258647B (en) | Externally-applied cherokee rose fruit/morinda officinalis/fenugreek powder for treating male impotence | |
CN101274027B (en) | Oral medicament, hot administration powder for curing femoral head necrosis | |
CN101618200B (en) | Externally-applied plaster for specially treating cervical spondylosis and preparation method thereof | |
CN100563674C (en) | Double sticking double effect plaster by internal and external combined treatment | |
CN106109695A (en) | One can effectively treat osteoporotic pill medicine and preparation method thereof | |
CN105521391A (en) | Traditional Chinese medicine for tonifying liver and kidney and for strengthening bones and muscles and preparation method of traditional Chinese medicine | |
CN105641187A (en) | Far-infrared therapeutic plaster | |
CN105327064A (en) | Traditional Chinese medicinal preparation for treating climacteric arthritis | |
CN104771519A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100217 Termination date: 20101217 |